Key result
Intensive lifestyle intervention fails to reduce overall CV events but cuts risk ~35% in specific subgroups.
Why the study?
The study was conducted to evaluate the heterogeneity of treatment effects of intensive lifestyle intervention in adults with type 2 diabetes and overweight or obesity, aiming to identify subgroups with greater cardiovascular benefits.
Does intensive lifestyle intervention reduce cardiovascular outcomes in adults with type 2 diabetes and overweight/obesity?
RCT (n=4,710)
Randomized
Yes
Does intensive lifestyle intervention reduce cardiovascular outcomes in adults with type 2 diabetes and overweight/obesity?
Hazard Ratio: 0.96 (95% CI 0.83–1.11)
Absolute Event Rate: 15.9% vs 16.6%
p-value: p=0.570
Intensive lifestyle intervention significantly reduces cardiovascular events in a specific subgroup of overweight/obese adults with type 2 diabetes characterized by better mental health and poorer renal function.
No immediate practice change from subgroup analysis; leaves open need for prospective validation of heterogeneous lifestyle intervention effects in diabetes.
OBJECTIVE: To evaluate the heterogeneity of treatment effects (HTEs) of intensive lifestyle intervention (ILI) in adults with type 2 diabetes and overweight/obesity, and identify a subgroup with greater cardiovascular benefits from ILI. METHODS: In a post-hoc analysis of the Look AHEAD trial, causal forest modeling was used to identify HTEs of ILI. The study population was stratified into four subgroups, and the associations of ILI with cardiovascular outcomes were assessed using multivariable Cox modeling compared to diabetes support & education (DSE). RESULTS: Among 4710 participants (mean age 58.9 years, 58.5% women), 768 primary outcomes occurred over a median follow-up of 9.5 years. Key variables identified through causal forest modeling were SF-36 mental health, diabetes duration, and urine albumin-creatinine ratio (ACR). In Subgroup 4 (SF-36 mental health > 55.64 and ACR > 10 mg/g), which had more cardiovascular risk factors and comorbidities, ILI significantly reduced the primary outcome risk (HR: 0.65, 95% CI: 0.48-0.87, P = 0.004) and three secondary outcomes compared to DSE. No cardiovascular benefits were observed in participants with SF-36 mental health ≤ 55.64 or ACR < 10 mg/g. CONCLUSION: This post-hoc analysis of the Look AHEAD trial showed HTEs of ILI in adults with type 2 diabetes and overweight/obesity. Participants with better mental health, poorer renal function, and more cardiovascular risk factors were more likely to benefit from ILI.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) conducted an RCT in Type 2 diabetes and overweight/obesity (n=4,710). Intensive lifestyle intervention vs. Diabetes support & education was evaluated on Composite of death from cardiovascular causes, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for angina (HR 0.96, 95% CI 0.83-1.11, p=0.570). Intensive lifestyle intervention did not significantly reduce cardiovascular events in the overall cohort (HR 0.96), but causal forest analysis revealed a 35% risk reduction (HR 0.65) in a subgroup with better mental health and poorer renal function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: